Granted Patent
B2
US 8,937,182 · App. 13/641,917 · Granted Jan 20, 2015
Synthesis for thiazolidinedione compounds
Inventors:
James R. Zeller (Scottsdale, AZ); Steven P. Tanis (Carlsbad, CA); Scott D. Larsen (South Lyon, MI); Timothy Parker (Portage, MI)
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides novel methods for synthesizing PPARγ sparing compounds, e.g., thiazolidinediones, that are useful for preventing and/or treating metabolic disorders such as diabetes, obesity, hypertension, and inflammatory diseases.
Claims (1)
1. A compound having the structure
Assignments (5)
CHANGE OF NAME
Recorded May 12, 2017
From: OCTETA THERAPEUTICS, LLC
To: CIRIUS THERAPEUTICS, INC.
Reel/Frame 042457/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 17, 2016
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: OCTETA THERAPEUTICS, LLC
Reel/Frame 039464/0837 →
RELEASE OF SECURITY INTEREST
Recorded May 19, 2016
From: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 038652/0097 →
SECURITY AGREEMENT
Recorded Feb 5, 2014
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: SQUARE 1 BANK
Reel/Frame 032162/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 22, 2013
From: ZELLER, JAMES R.; TANIS, STEVEN P.; LARSEN, SCOTT D.; PARKER, TIMOTHY
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 030465/0093 →
Continuity (3)
Provisional Application
61325502
· Apr 19, 2010
Provisional Application
61327498
· Apr 23, 2010